Literature DB >> 33529162

The knowns and unknowns of latent Mycobacterium tuberculosis infection.

W Henry Boom1,2,3, Ulrich E Schaible4,5, Jacqueline M Achkar6,7.   

Abstract

Humans have been infected with Mycobacterium tuberculosis (Mtb) for thousands of years. While tuberculosis (TB), one of the deadliest infectious diseases, is caused by uncontrolled Mtb infection, over 90% of presumed infected individuals remain asymptomatic and contain Mtb in a latent TB infection (LTBI) without ever developing disease, and some may clear the infection. A small number of heavily Mtb-exposed individuals appear to resist developing traditional LTBI. Because Mtb has mechanisms for intracellular survival and immune evasion, successful control involves all of the arms of the immune system. Here, we focus on immune responses to Mtb in humans and nonhuman primates and discuss new concepts and outline major knowledge gaps in our understanding of LTBI, ranging from the earliest events of exposure and infection to success or failure of Mtb control.

Entities:  

Mesh:

Year:  2021        PMID: 33529162      PMCID: PMC7843221          DOI: 10.1172/JCI136222

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  149 in total

1.  Risk of tuberculosis after recent exposure. A 10-year follow-up study of contacts in Amsterdam.

Authors:  Rosa Sloot; Maarten F Schim van der Loeff; Peter M Kouw; Martien W Borgdorff
Journal:  Am J Respir Crit Care Med       Date:  2014-11-01       Impact factor: 21.405

2.  B-lymphocytes forming follicle-like structures in the lung tissue of tuberculosis-infected mice: Dynamics, phenotypes and functional activity.

Authors:  Irina Linge; Alexander Dyatlov; Elena Kondratieva; Vadim Avdienko; Alexander Apt; Tatiana Kondratieva
Journal:  Tuberculosis (Edinb)       Date:  2016-11-17       Impact factor: 3.131

Review 3.  CD8 T cells and Mycobacterium tuberculosis infection.

Authors:  Philana Ling Lin; JoAnne L Flynn
Journal:  Semin Immunopathol       Date:  2015-04-28       Impact factor: 9.623

4.  Early Changes by (18)Fluorodeoxyglucose positron emission tomography coregistered with computed tomography predict outcome after Mycobacterium tuberculosis infection in cynomolgus macaques.

Authors:  M Teresa Coleman; Pauline Maiello; Jaime Tomko; Lonnie James Frye; Daniel Fillmore; Christopher Janssen; Edwin Klein; Philana Ling Lin
Journal:  Infect Immun       Date:  2014-03-24       Impact factor: 3.441

5.  Progression from latent infection to active disease in dynamic tuberculosis transmission models: a systematic review of the validity of modelling assumptions.

Authors:  Nicolas A Menzies; Emory Wolf; David Connors; Meghan Bellerose; Alyssa N Sbarra; Ted Cohen; Andrew N Hill; Reza Yaesoubi; Kara Galer; Peter J White; Ibrahim Abubakar; Joshua A Salomon
Journal:  Lancet Infect Dis       Date:  2018-04-10       Impact factor: 25.071

Review 6.  Macrophage Inducible C-Type Lectin As a Multifunctional Player in Immunity.

Authors:  Emmanuel C Patin; Selinda Jane Orr; Ulrich E Schaible
Journal:  Front Immunol       Date:  2017-07-25       Impact factor: 7.561

Review 7.  Immunological mechanisms of human resistance to persistent Mycobacterium tuberculosis infection.

Authors:  Jason D Simmons; Catherine M Stein; Chetan Seshadri; Monica Campo; Galit Alter; Sarah Fortune; Erwin Schurr; Robert S Wallis; Gavin Churchyard; Harriet Mayanja-Kizza; W Henry Boom; Thomas R Hawn
Journal:  Nat Rev Immunol       Date:  2018-09       Impact factor: 108.555

8.  Mycobacterium tuberculosis-Infected Hematopoietic Stem and Progenitor Cells Unable to Express Inducible Nitric Oxide Synthase Propagate Tuberculosis in Mice.

Authors:  Stephen T Reece; Alexis Vogelzang; Julia Tornack; Wolfgang Bauer; Ulrike Zedler; Sandra Schommer-Leitner; Georg Stingl; Fritz Melchers; Stefan H E Kaufmann
Journal:  J Infect Dis       Date:  2018-04-23       Impact factor: 5.226

Review 9.  The current state of animal models and genomic approaches towards identifying and validating molecular determinants of Mycobacterium tuberculosis infection and tuberculosis disease.

Authors:  Allison N Bucsan; Smriti Mehra; Shabaana A Khader; Deepak Kaushal
Journal:  Pathog Dis       Date:  2019-06-01       Impact factor: 3.166

10.  Antibody Fc Glycosylation Discriminates Between Latent and Active Tuberculosis.

Authors:  Lenette L Lu; Jishnu Das; Patricia S Grace; Sarah M Fortune; Blanca I Restrepo; Galit Alter
Journal:  J Infect Dis       Date:  2020-11-13       Impact factor: 5.226

View more
  11 in total

1.  Tuberculostearic Acid-Containing Phosphatidylinositols as Markers of Bacterial Burden in Tuberculosis.

Authors:  Julius Brandenburg; Jan Heyckendorf; Franziska Marwitz; Nicole Zehethofer; Lara Linnemann; Nicolas Gisch; Hande Karaköse; Maja Reimann; Katharina Kranzer; Barbara Kalsdorf; Patricia Sanchez-Carballo; Michael Weinkauf; Verena Scholz; Sven Malm; Susanne Homolka; Karoline I Gaede; Christian Herzmann; Ulrich E Schaible; Christoph Hölscher; Norbert Reiling; Dominik Schwudke
Journal:  ACS Infect Dis       Date:  2022-06-28       Impact factor: 5.578

2.  Characterizing Early T Cell Responses in Nonhuman Primate Model of Tuberculosis.

Authors:  Riti Sharan; Dhiraj Kumar Singh; Jyothi Rengarajan; Deepak Kaushal
Journal:  Front Immunol       Date:  2021-08-17       Impact factor: 8.786

Review 3.  Anti-tuberculosis treatment strategies and drug development: challenges and priorities.

Authors:  Véronique A Dartois; Eric J Rubin
Journal:  Nat Rev Microbiol       Date:  2022-04-27       Impact factor: 78.297

4.  Immuno-Diagnosis of Active Tuberculosis by a Combination of Cytokines/Chemokines Induced by Two Stage-Specific Mycobacterial Antigens: A Pilot Study in a Low TB Incidence Country.

Authors:  Violette Dirix; Philippe Collart; Anne Van Praet; Maya Hites; Nicolas Dauby; Sabine Allard; Judith Racapé; Mahavir Singh; Camille Locht; Françoise Mascart; Véronique Corbière
Journal:  Front Immunol       Date:  2022-03-10       Impact factor: 7.561

5.  Optimal Detection of Latent Mycobacterium tuberculosis Infection by Combined Heparin-Binding Hemagglutinin (HBHA) and Early Secreted Antigenic Target 6 (ESAT-6) Whole-Blood Interferon Gamma Release Assays.

Authors:  V Dirix; N Dauby; M Hites; E Watelet; A Van Praet; A Godefroid; E Petit; M Singh; C Locht; F Mascart; V Corbière
Journal:  J Clin Microbiol       Date:  2022-04-18       Impact factor: 11.677

Review 6.  Immune evasion and provocation by Mycobacterium tuberculosis.

Authors:  Pallavi Chandra; Steven J Grigsby; Jennifer A Philips
Journal:  Nat Rev Microbiol       Date:  2022-07-25       Impact factor: 78.297

7.  Monocyte Transcriptional Responses to Mycobacterium tuberculosis Associate with Resistance to Tuberculin Skin Test and Interferon Gamma Release Assay Conversion.

Authors:  Jason D Simmons; Kimberly A Dill-McFarland; Catherine M Stein; Phu T Van; Violet Chihota; Thobani Ntshiqa; Pholo Maenetje; Glenna J Peterson; Penelope Benchek; Mary Nsereko; Kavindhran Velen; Katherine L Fielding; Alison D Grant; Raphael Gottardo; Harriet Mayanja-Kizza; Robert S Wallis; Gavin Churchyard; W Henry Boom; Thomas R Hawn
Journal:  mSphere       Date:  2022-06-13       Impact factor: 5.029

Review 8.  Feasibility of novel approaches to detect viable Mycobacterium tuberculosis within the spectrum of the tuberculosis disease.

Authors:  Sogol Alebouyeh; Brian Weinrick; Jacqueline M Achkar; Maria J García; Rafael Prados-Rosales
Journal:  Front Med (Lausanne)       Date:  2022-08-22

9.  Immune responses in COVID-19 and tuberculosis coinfection: A scoping review.

Authors:  Kevin Flores-Lovon; Brando Ortiz-Saavedra; Luis A Cueva-Chicaña; Shalom Aperrigue-Lira; Elizbet S Montes-Madariaga; David R Soriano-Moreno; Brett Bell; Rodney Macedo
Journal:  Front Immunol       Date:  2022-08-26       Impact factor: 8.786

10.  Structural Changes in the Cap of Rv0183/mtbMGL Modulate the Shape of the Binding Pocket.

Authors:  Christoph Grininger; Mario Leypold; Philipp Aschauer; Tea Pavkov-Keller; Lina Riegler-Berket; Rolf Breinbauer; Monika Oberer
Journal:  Biomolecules       Date:  2021-09-01
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.